Create various new sections of KRS Chapter 211 to define terms; establish the urgent-need insulin program and the continuing access to insulin program; establish eligibility guidelines for both programs; establish the application process; establish the process by which insulin is dispensed to eligible individuals; establish the responsibilities of insulin manufacturers for facilitating the dispensing of insulin to eligible individuals; establish the responsibilities of the Kentucky Board of Pharmacy for administering the program; require manufacturers to maintain privacy of all data obtained; require manufacturers to annually report certain information to the board; require the board to report certain information to the General Assembly upon request; establish penalties; EMERGENCY.